(Q44337613)

2 December 2017

title

Prolonged opioid blockade with naltrexone and luteinizing hormone modifications in women with polycystic ovarian syndrome (English)

1 reference

2 December 2017

0 references

0 references

A Cagnacci

1

1 reference

2 December 2017

R Soldani

2

1 reference

2 December 2017

A M Paoletti

3

1 reference

2 December 2017

A Falqui

4

1 reference

2 December 2017

G B Melis

5

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 August 1994

1 reference

2 December 2017

published in

Fertility and Sterility

1 reference

2 December 2017

volume

62

1 reference

2 December 2017

issue

2

1 reference

2 December 2017

page(s)

269-272

1 reference

Polycystic ovarian disease: a challenge and controversy

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956877-0

Central opioid activity in polycystic ovary syndrome with and without dopaminergic modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956877-0

Evidence for decreased endogenous dopamine and opioid inhibitory influences on LH secretion in polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956877-0

Relation of endogenous opioid peptides and morphine to neuroendocrine functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956877-0

The role of endogenous opiates in LH secretion during the menstrual cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956877-0

Evidence that Estrogens Inhibit LH Secretion through Opioids in Postmenopausal Women Using Naloxone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956877-0

Enkephalins and Pituitary Hormone Release Modification of Responsiveness to LHRH

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956877-0

Opioids modulate pituitary receptors for gonadotropin-releasing hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956877-0

Effects of transdermal 17 beta-estradiol treatment and naloxone infusion on gonadotropin response to gonadotropin-releasing hormone in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956877-0

beta-Endorphin and beta-lipotropin plasma levels in hirsute women: correlation with body weight

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956877-0

Elevated plasma levels of β-endorphin in a group of women with polycystic ovarian disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956877-0

Increased circulating levels of immunoreactive beta-endorphin in polycystic ovary syndrome is not caused by increased pituitary secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956877-0

Sustained effects of opioid antagonism during the normal human luteal phase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956877-0

Influence of oestradiol and progesterone on pulsatile LH secretion in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956877-0

The interaction between mediobasohypothalamic dopaminergic and endorphinergic neuronal systems as a key regulator of reproduction: an hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956877-0

beta-Endorphin stimulates the secretion of insulin and glucagon in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956877-0

Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956877-0

Pulsatile luteinizing hormone secretion in hypothalamic amenorrhea, anorexia nervosa, and polycystic ovarian disease during naltrexone treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956877-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0015-0282(16)56877-0

1 reference

2 December 2017

1 reference